UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POS0333 ALTERED MACROPHAGE POLARIZATION PHENOTYPES IN SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.394-394

2021

Volltextzugriff (PDF)

FRI0420 Altered transcriptome of circulating cd14+ monocytes in systemic sclerosis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.740

2018

Volltextzugriff (PDF)

Nestin expression--a property of multi-lineage progenitor cells?

Cellular and molecular life sciences : CMLS, 2004-10, Vol.61 (19-20), p.2510-2522

2004

Volltextzugriff (PDF)

FRI0439 The Role of the Myeloid Inflammatory Bone Marrow Compartment in Onset and Progression of Myocardial Fibrosis in Systemic Sclerosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.586-586

2015

Volltextzugriff (PDF)

OP0049 Myocardial Fibrogenesis in Systemic Sclerosis: Involvement of A Novel Stromal Sub-Population

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.73-73

2016

Volltextzugriff (PDF)

Potential of Embryonic and Adult Stem Cells in vitro

Biological chemistry, 2003-10, Vol.384 (10-11), p.1391-1409

2003

Volltextzugriff (PDF)

Novel therapeutic options in inflammatory cardiomyopathy

Swiss medical weekly, 2013-08, Vol.143, p.w13841

2013

Volltextzugriff (PDF)

OP0289 Micrornas as Potential Regulators of Monocyte Differentiation and Function in Heart Fibrosis in Systemic Sclerosis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.167-167

2016

Volltextzugriff (PDF)

POS0428 REGULATION OF IFN SIGNATURE BY HDAC CLASS IIa-CD52 AXIS IN SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.442-443

2021

Volltextzugriff (PDF)

Single cell RNA sequencing to dissect transcriptional signature of cardiac fibroblasts activation in experimental autoimmune myocarditis

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

AB0151 DYSFERLIN AS A POTENTIAL ANTI-FIBROTIC PROTEIN INVOLVED IN TGF-Β/FOSL-2/AUTOPHAGY CROSSTALKING IN CARDIAC FIBROBLASTS UNDER IMMUNOFIBROTIC CONDITIONS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1255-1255

2023

Volltextzugriff (PDF)

POS0625 EFFECTS OF DIFFERENTIATION STAGES OF HEALTHY AND SSc MACROPHAGES ON THE 3D HUMAN CARDIAC FIBROSIS MODEL

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.586-587

2023

Volltextzugriff (PDF)

POS0559 DISCOVERING BLOOD-BASED BIOMARKERS FOR SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1031-1032

2024

Volltextzugriff (PDF)

POS0470 FOSL-2 TRANSCRIPTION FACTOR REGULATES MACROPHAGE POLARIZATION AND PHAGOCYTOSIS IN SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.489-490

2022

Volltextzugriff (PDF)

TNF-alpha protects from exacerbated autoinflammatory response in mouse model of experimental autoimmune myocarditis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

POS0486 IDENTIFICATION OF NEW CANDIDATE TARGETS INVOLVED IN ACTIVATION OF CARDIAC FIBROBLASTS UNDER IMMUNOFIBROTIC CONDITIONS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.498-498

2022

Volltextzugriff (PDF)

Myocarditis triggers inflammatory response in cardiac fibroblasts and profibrotic activation of myeloid and endothelial cells in mouse model of experimental autoimmune myocarditis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Activated myofibroblasts promote cardiac hypertrophy and systolic dysfunction independently of cardiac fibrosis in experimental autoimmune myocarditis

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Activation of cardiac macrophages, endothelial cells and fibroblasts in experimental autoimmune myocarditis

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

POS0479 STAT3 DEGRADERS PROTECT FROM IMMUNOFIBROTIC CHANGES IN PRECLINICAL MODELS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.494-495

2022

Volltextzugriff (PDF)

AB0147 ANTI-FIBROTIC EFFECTS OF MT-5562, A NOVEL POTENT SELECTIVE AUTOTAXIN INHIBITOR, IN PRECLINICAL STUDIES: CLUES TO TREAT SKIN AND LUNG FIBROSIS IN SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1253-1253

2023

Volltextzugriff (PDF)

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis

Rheumatology (Oxford, England), 2023-08, Vol.62 (8), p.2918-2929

2023

Volltextzugriff (PDF)

POS0467 DERSIMELAGON, A NOVEL ORAL MELANOCORTIN 1 RECEPTOR AGONIST, DEMONSTRATES DISEASE-MODIFYING EFFECTS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.488-488

2022

Volltextzugriff (PDF)

IL-23 promotes T-cell mediated cardiac inflammation but protects the heart from fibrosis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

P6295Role of angiotensin II receptor type 1 in TGF-beta-mediated fibrogenesis in mouse model of experimental autoimmune myocarditis

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaMicroscopy, Fluorescence

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

POS0333 ALTERED MACROPHAGE POLARIZATION PHENOTYPES IN SYSTEMIC SCLEROSIS

FRI0420 Altered transcriptome of circulating cd14+ monocytes in systemic sclerosis

Nestin expression--a property of multi-lineage progenitor cells?

FRI0439 The Role of the Myeloid Inflammatory Bone Marrow Compartment in Onset and Progression of Myocardial Fibrosis in Systemic Sclerosis

OP0049 Myocardial Fibrogenesis in Systemic Sclerosis: Involvement of A Novel Stromal Sub-Population

Potential of Embryonic and Adult Stem Cells in vitro

Novel therapeutic options in inflammatory cardiomyopathy

OP0289 Micrornas as Potential Regulators of Monocyte Differentiation and Function in Heart Fibrosis in Systemic Sclerosis

POS0428 REGULATION OF IFN SIGNATURE BY HDAC CLASS IIa-CD52 AXIS IN SYSTEMIC SCLEROSIS

Single cell RNA sequencing to dissect transcriptional signature of cardiac fibroblasts activation in experimental autoimmune myocarditis

AB0151 DYSFERLIN AS A POTENTIAL ANTI-FIBROTIC PROTEIN INVOLVED IN TGF-Β/FOSL-2/AUTOPHAGY CROSSTALKING IN CARDIAC FIBROBLASTS UNDER IMMUNOFIBROTIC CONDITIONS

POS0625 EFFECTS OF DIFFERENTIATION STAGES OF HEALTHY AND SSc MACROPHAGES ON THE 3D HUMAN CARDIAC FIBROSIS MODEL

POS0559 DISCOVERING BLOOD-BASED BIOMARKERS FOR SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION

POS0470 FOSL-2 TRANSCRIPTION FACTOR REGULATES MACROPHAGE POLARIZATION AND PHAGOCYTOSIS IN SYSTEMIC SCLEROSIS

TNF-alpha protects from exacerbated autoinflammatory response in mouse model of experimental autoimmune myocarditis

POS0486 IDENTIFICATION OF NEW CANDIDATE TARGETS INVOLVED IN ACTIVATION OF CARDIAC FIBROBLASTS UNDER IMMUNOFIBROTIC CONDITIONS

Myocarditis triggers inflammatory response in cardiac fibroblasts and profibrotic activation of myeloid and endothelial cells in mouse model of experimental autoimmune myocarditis

Activated myofibroblasts promote cardiac hypertrophy and systolic dysfunction independently of cardiac fibrosis in experimental autoimmune myocarditis

Activation of cardiac macrophages, endothelial cells and fibroblasts in experimental autoimmune myocarditis

POS0479 STAT3 DEGRADERS PROTECT FROM IMMUNOFIBROTIC CHANGES IN PRECLINICAL MODELS

AB0147 ANTI-FIBROTIC EFFECTS OF MT-5562, A NOVEL POTENT SELECTIVE AUTOTAXIN INHIBITOR, IN PRECLINICAL STUDIES: CLUES TO TREAT SKIN AND LUNG FIBROSIS IN SYSTEMIC SCLEROSIS

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis

POS0467 DERSIMELAGON, A NOVEL ORAL MELANOCORTIN 1 RECEPTOR AGONIST, DEMONSTRATES DISEASE-MODIFYING EFFECTS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS

IL-23 promotes T-cell mediated cardiac inflammation but protects the heart from fibrosis

P6295Role of angiotensin II receptor type 1 in TGF-beta-mediated fibrogenesis in mouse model of experimental autoimmune myocarditis

Aktive Filter

Suchergebnisse filtern